{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-177539","form_type":"8-K","ticker":"FNCHQ","cik":"0001733257","company_name":"Finch Therapeutics Group, Inc.","filed_at":"2023-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.287435+00:00","generated_at":"2026-06-13T15:36:37.753810+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Finch Therapeutics regains compliance with Nasdaq minimum bid price requirement","bullets":["Received letter from Nasdaq on June 27, 2023 confirming regained compliance with Listing Rule 5450(a)(1).","Closing bid price was $1.00 or greater for 10 consecutive business days from June 12 to June 26, 2023.","Previously notified of deficiency on Dec 30, 2022; compliance deadline was June 28, 2023.","Nasdaq considers the compliance matter closed; no further action required."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-177539","json":"https://secwatch.observer/filing/0001193125-23-177539.json","markdown":"https://secwatch.observer/filing/0001193125-23-177539.md","text":"https://secwatch.observer/filing/0001193125-23-177539.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1733257/000119312523177539/0001193125-23-177539-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1733257/000119312523177539/d510150d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T15:36:37.753810+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}